Pulmonary Drug Delivery Companies have developed new drug delivery systems that can reduce the side effects of drugs while increasing patient compliance. The big money factor here is the extension of market exclusivity to pharmaceutical companies like PFE which is expected to file a NDA for an inhaleable insulin treatment for diabetes in 2001. Also in development are drugs for asthma, multiple sclerosis, infertility, pain management (morphine), growth hormones and many others. According to Decision Resources the Drug Delivery Sector will grow from $6 billion in 1997 to $120 billion by 2007 making the companies on the Pulmonary Drug Delivery List some potentially huge winners. You may also be interested in our Biotechnology List.

The Pulmonary Drug Delivery List

ALKS ARDM INHL

ALKS through NKTR

Partner Companies

BDX BIIB LLY NVO PFE

BDX through PFE

Let me see a chart at Big Charts

Let me search for more news:
SEARCH YAHOO NEWS